These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 16469112

  • 1. First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215].
    Wittenberg RH, Schell E, Krehan G, Maeumbaed R, Runge H, Schlüter P, Fashola TO, Thurston HJ, Burger KJ, Trechsel U.
    Arthritis Res Ther; 2006; 8(2):R35. PubMed ID: 16469112
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo.
    Sheldon E, Beaulieu A, Paster Z, Dutta D, Yu S, Sloan VS.
    Clin Ther; 2005 Jan; 27(1):64-77. PubMed ID: 15763607
    [Abstract] [Full Text] [Related]

  • 3. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib.
    Fleischmann R, Sheldon E, Maldonado-Cocco J, Dutta D, Yu S, Sloan VS.
    Clin Rheumatol; 2006 Feb; 25(1):42-53. PubMed ID: 16132165
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib.
    Lehmann R, Brzosko M, Kopsa P, Nischik R, Kreisse A, Thurston H, Litschig S, Sloan VS.
    Curr Med Res Opin; 2005 Apr; 21(4):517-26. PubMed ID: 15899100
    [Abstract] [Full Text] [Related]

  • 5. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib.
    Tannenbaum H, Berenbaum F, Reginster JY, Zacher J, Robinson J, Poor G, Bliddal H, Uebelhart D, Adami S, Navarro F, Lee A, Moore A, Gimona A.
    Ann Rheum Dis; 2004 Nov; 63(11):1419-26. PubMed ID: 15020310
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the patient acceptable symptom state in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis.
    Dougados M, Moore A, Yu S, Gitton X.
    Arthritis Res Ther; 2007 Nov; 9(1):R11. PubMed ID: 17266764
    [Abstract] [Full Text] [Related]

  • 7. Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: a randomised controlled trial in patients with osteoarthritis.
    Fleischmann R, Tannenbaum H, Patel NP, Notter M, Sallstig P, Reginster JY.
    BMC Musculoskelet Disord; 2008 Mar 07; 9():32. PubMed ID: 18328090
    [Abstract] [Full Text] [Related]

  • 8. Lumiracoxib 400 mg compared with celecoxib 400 mg and placebo for treating pain following dental surgery: a randomized, controlled trial.
    Fricke J, Davis N, Yu V, Krammer G.
    J Pain; 2008 Jan 07; 9(1):20-7. PubMed ID: 17933588
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
    Kivitz A, Fairfax M, Sheldon EA, Xiang Q, Jones BA, Gammaitoni AR, Gould EM.
    Clin Ther; 2008 Dec 07; 30(12):2366-77. PubMed ID: 19167595
    [Abstract] [Full Text] [Related]

  • 10. A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint.
    Park YG, Ha CW, Han CD, Bin SI, Kim HC, Jung YB, Lim HC.
    J Ethnopharmacol; 2013 Oct 07; 149(3):816-24. PubMed ID: 23954277
    [Abstract] [Full Text] [Related]

  • 11. Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial.
    DeLemos BP, Xiang J, Benson C, Gana TJ, Pascual ML, Rosanna R, Fleming B.
    Am J Ther; 2011 May 07; 18(3):216-26. PubMed ID: 20215961
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: a phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial.
    Schnitzer TJ, Beier J, Geusens P, Hasler P, Patel SK, Senftleber I, Gitton X, Moore A, Sloan VS, Poór G.
    Arthritis Rheum; 2004 Aug 15; 51(4):549-57. PubMed ID: 15334426
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of additional 200-mg dose of celecoxib in adult patients with postoperative pain following extraction of impacted third mandibular molar: a multicenter, randomized, double-blind, placebo-controlled, phase II study in Japan.
    Saito K, Kaneko A, Machii K, Ohta H, Ohkura M, Suzuki M.
    Clin Ther; 2012 Feb 15; 34(2):314-28. PubMed ID: 22284900
    [Abstract] [Full Text] [Related]

  • 14. Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active- and placebo-controlled study.
    Cheung R, Krishnaswami S, Kowalski K.
    Clin Ther; 2007 Feb 15; 29 Suppl():2498-510. PubMed ID: 18164917
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial.
    Rother M, Lavins BJ, Kneer W, Lehnhardt K, Seidel EJ, Mazgareanu S.
    Ann Rheum Dis; 2007 Sep 15; 66(9):1178-83. PubMed ID: 17363401
    [Abstract] [Full Text] [Related]

  • 16. A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip.
    Luyten FP, Geusens P, Malaise M, De Clerck L, Westhovens R, Raeman F, Vander Mijnsbrugge D, Mathy L, Hauzeur JP, De Keyser F, Van den Bosch F.
    Ann Rheum Dis; 2007 Jan 15; 66(1):99-106. PubMed ID: 16815864
    [Abstract] [Full Text] [Related]

  • 17. A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain.
    Moberly JB, Xu J, Desjardins PJ, Daniels SE, Bandy DP, Lawson JE, Link AJ, Truitt KE.
    Clin Ther; 2007 Mar 15; 29(3):399-412. PubMed ID: 17577461
    [Abstract] [Full Text] [Related]

  • 18. The post-operative analgesic efficacy and tolerability of lumiracoxib compared with placebo and naproxen after total knee or hip arthroplasty.
    Chan VW, Clark AJ, Davis JC, Wolf RS, Kellstein D, Jayawardene S.
    Acta Anaesthesiol Scand; 2005 Nov 15; 49(10):1491-500. PubMed ID: 16223396
    [Abstract] [Full Text] [Related]

  • 19. Gastroduodenal safety and tolerability of lumiracoxib compared with Ibuprofen and celecoxib in patients with osteoarthritis.
    Hawkey CC, Svoboda P, Fiedorowicz-Fabrycy IF, Nasonov EL, Pikhlak EG, Cousin M, Gitton X, Hoexter G.
    J Rheumatol; 2004 Sep 15; 31(9):1804-10. PubMed ID: 15338504
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of lumiracoxib versus placebo in patients with osteoarthritis of the hand.
    Grifka JK, Zacher J, Brown JP, Seriolo B, Lee A, Moore A, Gimona A.
    Clin Exp Rheumatol; 2004 Sep 15; 22(5):589-96. PubMed ID: 15485012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.